Quick Answer
Moleculin Biotech, Inc. reported Net Income of -$33.56 million for fiscal year 2025.
Moleculin Biotech, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$33.56M | -28.8% |
| 2024 | -$26.05M | +12.5% |
| 2023 | -$29.77M | -2.6% |
| 2022 | -$29.02M | -82.6% |
| 2021 | -$15.89M | +8.4% |
| 2020 | -$17.36M | -31.4% |
| 2019 | -$13.21M | -11.2% |
| 2018 | -$11.88M | -21.1% |
| 2017 | -$9.80M | -149.7% |
| 2016 | -$3.93M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$25.40M | -261.6% | -42.6% |
| June 30, 2025 | -$17.81M | -196.1% | -201.6% |
| March 31, 2025 | -$5.90M | +8.1% | +15.9% |
| September 30, 2024 | -$7.02M | -25.2% | -16.8% |
| June 30, 2024 | -$6.01M | -0.7% | +6.4% |
| March 31, 2024 | -$6.42M | +18.8% | -14.5% |
| September 30, 2023 | -$5.61M | +34.9% | +6.1% |
| June 30, 2023 | -$5.98M | +11.8% | +24.5% |
- Moleculin Biotech, Inc. showed a decrease of -28.8% in Net Income compared to the prior fiscal year.
- Over the 2016–2025 period, Moleculin Biotech, Inc.’s net income has declined by 754.8% (from -$3.93 million to -$33.56 million).
- The most recent figure is from Moleculin Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: